Medical Tourism 2026: Hair Transplant, Dental, Plastic Surgery & More

Showing 1 - 6 of 6 medical tourism articles
Top 10 Most Expensive Cancer Drugs in the U.S. (2025 Update) - Medical Tourism Procedure

Top 10 Most Expensive Cancer Drugs in the U.S. (2025 Update)

36 views

In 2025, cancer treatment costs in the United States remain among the highest in the world, with several oncology drugs carrying annual price tags well over $150,000. This article breaks down the Top 10 most expensive cancer drugs in the U.S., comparing per-dose and per-year costs, highlighting manufacturers, and explaining what patients actually pay after insurance. From blockbuster immunotherapies like Keytruda and Imfinzi to groundbreaking CAR-T and gene therapies priced at nearly half a million dollars per treatment, this guide provides a clear look at the latest pricing landscape and practical insights for patients navigating financial support programs.

Keytruda Price Per Dose vs. Per Year — Full Breakdown (2025) - Medical Tourism Procedure

Keytruda Price Per Dose vs. Per Year — Full Breakdown (2025)

37 views

Keytruda (pembrolizumab) is one of the most widely prescribed immunotherapy drugs for cancer, but its cost continues to be a major concern for patients in 2025. On average, a single 200 mg intravenous dose is estimated at around $11,700 under Medicare ASP pricing, while a 6-week 400 mg dose carries a published list price of $23,590. Depending on the treatment plan, annual costs can exceed $200,000 per patient. In 2025, Merck also introduced a new subcutaneous formulation (Keytruda QLEX), which offers shorter administration times but could bring different pricing models compared to IV dosing. Insurance coverage, Medicare billing rules, and patient assistance programs remain critical factors in determining real out-of-pocket costs.

Keytruda Cost in 2025: Real Monthly Price, Insurance Coverage & Patient Tips - Medical Tourism Procedure

Keytruda Cost in 2025: Real Monthly Price, Insurance Coverage & Patient Tips

29 views

Keytruda (pembrolizumab) is one of the most widely prescribed immunotherapy drugs for cancer — but its high cost often leaves patients wondering how much they will actually pay. In 2025, the average list price for a single Keytruda infusion is around $11,000–$12,000, with annual costs exceeding $190,000 before insurance. Fortunately, Medicare, Medicaid, and private insurers cover most of these expenses, and copay assistance programs can reduce patient costs to as little as $25 per infusion. This guide explains the real monthly price of Keytruda in 2025, how insurance coverage works, and practical tips patients can use to lower out-of-pocket expenses.

Opdivo Cost per Month: Nivolumab Price & Insurance Coverage in the USA (2025) - Medical Tourism Procedure

Opdivo Cost per Month: Nivolumab Price & Insurance Coverage in the USA (2025)

44 views

Opdivo (nivolumab) is one of the most widely used immunotherapy drugs in the United States, but its cost can be overwhelming for many cancer patients. In 2025, the monthly price of Opdivo ranges from $15,000 to over $20,000 before insurance, depending on dosage and treatment schedule. The good news is that Medicare, private insurance, and financial assistance programs can reduce these expenses significantly, sometimes lowering patient out-of-pocket costs to only a few hundred dollars per month. This guide explains the real cost of Opdivo per month, how insurance coverage works, and what assistance options are available to help patients manage treatment expenses.

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025? - Medical Tourism Procedure

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025?

116 views

In 2025, the cost of Opdivo (Nivolumab) in the United States continues to be a major concern for cancer patients and families. With monthly expenses ranging from $12,000 to $26,000 without insurance, many wonder how they can afford this life-saving immunotherapy. This article explains the true price of Opdivo in 2025, how much insurance covers, available patient assistance programs, and how Opdivo compares to other cancer treatments like Keytruda and Yervoy. You’ll also find updated FAQs with trusted links to help patients make informed financial and medical decisions.

How Much Does Opdivo Cost in the USA? | Nivolumab Price 2025 - Medical Tourism Procedure

How Much Does Opdivo Cost in the USA? | Nivolumab Price 2025

176 views

In 2025, the cost of Opdivo (nivolumab) in the United States remains a major concern for cancer patients and caregivers. With list prices starting at around $7,600 per infusion and reaching over $36,000 per vial, understanding insurance coverage, financial assistance programs, and the newly approved subcutaneous form (Opdivo Qvantig) is essential. This guide explains the latest prices, cost-saving options, and answers the most common questions about Opdivo treatment in the U.S.

Medical Tourism FAQs: Hair, Dental, Surgery & Treatments

Turkey is the world leader in hair transplant procedures with over 500,000 procedures annually. Turkish clinics offer state-of-the-art technology, experienced surgeons, and affordable prices that are 60-70% lower than in Western countries.

Rhinoplasty in Dubai typically costs between $5,000 - $12,000 depending on the complexity of the procedure, the surgeon's experience, and the facility. Dubai offers world-class medical facilities with internationally trained surgeons.

Mexico, Turkey, and Hungary are among the top destinations for dental implants due to their combination of quality care, experienced dentists, and significant cost savings. Patients can save 50-70% compared to US prices while receiving excellent care.

Top Medical Tourism Destinations 2026: Turkey, Dubai & USA

Turkey Medical Tourism

World's leading destination for hair transplants and cosmetic surgery

Explore Turkey

Dubai Healthcare

Luxury medical treatments with world-class facilities

Explore Dubai

USA Medical Centers

Advanced medical technology and top specialists

Explore USA